Product Information
EVEROLIMUS 0.25 MG TABLET is a generic product labeled by Biocon Pharma Inc., priced at $2.1159 per EA under NDC 70377006911. Its NADAC has been published 34 times since Nov 5, 2025.
Strength
.25 mg/1
Manufacturer
Biocon Pharma Inc.NDC
70377006911
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
EVEROLIMUSApproval Type
Generic (ANDA)
FDA Application
ANDA216140On Market Since
6/2/2025
Pharmacological Classes
Price Statistics
The NADAC for EVEROLIMUS 0.25 MG TABLET has been published 34 times since Nov 5, 2025, and over the history we have for it it has declined 5.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $2.1159 per EA |
|---|---|
| All-time high | $2.3327 (Feb 11, 2026) |
| All-time low | $2.1134 (May 20, 2026) |
| 52-week high | $2.3327 |
| 52-week low | $2.1134 |
| Median price | $2.2432 |
| Average price | $2.2359 |
| Largest weekly change | -6.2% (Apr 22, 2026) |
| Weeks tracked | 34 |
| Tracking since | Nov 5, 2025 |
Generic Alternatives
The matcher finds 3 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 3 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of EVEROLIMUS 0.25 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for EVEROLIMUS 0.25 MG TABLET, manufactured by Biocon Pharma Inc., is $2.1159 per EA (NDC 70377006911), effective Jun 24, 2026.
How has the price of EVEROLIMUS 0.25 MG TABLET changed over time?
Over the history we have for it, the NADAC for EVEROLIMUS 0.25 MG TABLET has declined 5.6%. It has been tracked across 34 weekly CMS publications since Nov 5, 2025.
What are the highest and lowest recorded NADAC prices for EVEROLIMUS 0.25 MG TABLET?
Since Nov 5, 2025, the NADAC for EVEROLIMUS 0.25 MG TABLET has ranged from a low of $2.1134 (May 20, 2026) to a high of $2.3327 (Feb 11, 2026), with a median of $2.2432 per EA.
Are there cheaper alternatives to EVEROLIMUS 0.25 MG TABLET?
3 NADAC-published products share the same active ingredient, strength, and dosage form as EVEROLIMUS 0.25 MG TABLET, but none are currently priced below it.
Who manufactures EVEROLIMUS 0.25 MG TABLET?
EVEROLIMUS 0.25 MG TABLET (NDC 70377006911) is labeled by Biocon Pharma Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification